Nutex Health Q2 revenue up 29% to $76.1M; Adjusted EBITDA up 200% to $12.0M

Nutex Health Inc.

2024-Q2 EPS reported -$0.15 revenue$143,536,048

Net loss attributable to Nutex of $0.4M vs $3.5M loss in Q2 2023; H1 net loss $0.7M vs $8.6M.
Hospital division visits 41,208 in Q2 (+28% YoY); mature hospital revenue +13.2%.
Adjusted EBITDA (attributable) $12.0M in Q2, up 200% YoY; H1 Adjusted EBITDA $16.6M (+159%).
Operating cash flow of $16.3M in H1 2024; cash $40.8M, long-term debt $22.4M.
Non-cash impairments of $3.5M assets and $3.2M goodwill; $3.1M gain on warrant liability.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.